account_balance
Investment manager · 13F filer · SEC CIK 1633313
Avoro Capital Advisors LLC
Reported value$11.1Bas of Jun 30, 2026
Positions26 3 new, 7 sold out
Top 10 weight79%UTHR alone is 14%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
UTHR
United Therapeutics Corp
13.5%Added
ASND
Ascendis Pharma
12.2%New
KRYS
Krystal Biotech INC
9.6%
MDGL
Madrigal Pharmaceuticals INC
8.8%
ARGX
Argenx Se
8.3%
ARWR
Arrowhead Pharmaceuticals INC
8.3%Added
KYMR
Kymera Therapeutics INC
7.7%
RVMD
Revolution Medicines INC
3.9%Trimmed
CYTK
Cytokinetics INC
3.8%Added
CELC
Celcuity INC
3.2%
16 others
20.5%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed